Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDX18P3 is classified as a pseudogene, meaning it is a genomic sequence similar to the protein-coding gene *DEAD-box helicase 18 (DDX18)* but is generally non-functional and does not encode a functional protein[3]. The canonical DDX18 gene encodes an ATP-dependent RNA helicase involved in RNA metabolism, including ribosome biogenesis, R-loop homeostasis, and pluripotency regulation[1][3]. Pseudogenes may arise from gene duplication or retrotransposition events, and their transcripts, if expressed, typically do not result in functional proteins or participate in known biological pathways or therapeutic mechanisms[3]. There is no established evidence of DDX18P3 functioning as a receptor, enzyme, transporter, or therapeutic target, nor does it have validated roles in disease, drug interaction, biomarker usage, or safety concerns. As a result, DDX18P3 should not be considered a therapeutic target or functional molecule by current scientific standards. If you intended the protein-coding gene **DEAD-box helicase 18 (DDX18)**, that molecule is a biologically active ATP-dependent RNA helicase implicated in ribosome biogenesis and gene regulation, and is associated with Bloom syndrome and pluripotency in embryonic stem cells[1][3]. However, DDX18P3 refers specifically to a pseudogene, not the functional DDX18 protein[3]. If more information about the functional DDX18 gene or corrections to the name are desired, please specify.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 18 pseudogene 3 (DDX18P3).